Meta-analysis found that high-dose psilocybin was more effective than ... including adjustments for baseline depression severity and exclusion of high-risk bias studies, supported these findings.

In addition, high dose psilocybin ... inclusion and exclusion parameters also limited the researchers, so future research could include different parameters and inclusion criteria.

Two similar randomized controlled trials in late-stage cancer patients suggest that a single, high ... psilocybin-first group, 58% met criteria for anxiolytic response 7 weeks after receiving dose ...

Opens in a new tab or window NEW ORLEANS -- When combined with psychological support, just one dose of psilocybin therapy ... in the study site country. Exclusion criteria included a history ...

Patients treated with high-dose psilocybin had better responses compared with placebo in antidepressant trials. Placebo response was greater in antidepressant vs. psychedelic trials. High-dose ...

WEDNESDAY, Aug. 28, 2024 (HealthDay News) -- Patients treated with high-dose psilocybin have better responses than those treated with placebo in antidepressant trials, according to a study ...

Following up on their landmark 2016 study, researchers found that a one-time, single-dose treatment of psilocybin ... to 80 percent of participants met criteria for clinically significant ...

Image Credit: YAR Photographer / Shutterstock.com Meta-analysis found that high-dose psilocybin was more effective ... baseline depression severity and exclusion of high-risk bias studies ...